naion glp-1 NAION: New MDL for Ozempic and Other GLP-1 Drugs Linked to Vision Loss

What the diabetologist needs to know about the risk of non-arteritic anterior ischaemic optic neuropathy and GLP-1 receptor agonist use in patients with type 2 diabetes

26.61

★★★★☆4.8 (126)

𝐀𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐢𝐨𝐧 𝐁𝐞𝐭𝐰𝐞𝐞𝐧 𝐆𝐋𝐏-1 𝐑𝐞𝐜𝐞𝐩𝐭𝐨𝐫 𝐀𝐠𝐨𝐧𝐢𝐬𝐭𝐬 𝐚𝐧𝐝 𝐈𝐬𝐜𝐡𝐞𝐦𝐢𝐜 𝐎𝐩𝐭𝐢𝐜 𝐍𝐞𝐮𝐫𝐨𝐩𝐚𝐭𝐡𝐲: 𝐀 𝐌𝐞𝐭𝐚-𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 Very interesting meta-analysis…

29.94

★★★★★4.9 (98)

ICYMI: What study to date has shown the strongest evidence of a positive association between #GLP-1 RA use and #NAION? #Endocrinology #ESReadingRoom @EndocrineSociety

20.85

★★★★★5.0 (157)

Large US Study Adds to Connection Between NAION Risks and GLP-1 Drugs

24.23

★★★★★4.7 (84)

Many have named Ozempic, a well-known GLP-1 medication, the “miracle drug” for its astounding ability to help patients lose weight and better control their diabetes. But recent studies report visual side effects,

28.91

★★★★★4.9 (203)

This systematic review and meta-analysis assessed the association between GLP-1RA use and nonarteritic anterior ischemic optic neuropathy (NAION) risk: https://hubs.la/Q04hKk2Z0

29.63

★★★★★5.0 (176)

Navigating GLP-1 and Pregnancy: Insights, Safety, and Postpartum Considerations

27.93

★★★★★4.8 (132)